243 related articles for article (PubMed ID: 32360180)
21. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
Zhu HE; Yin JY; Chen DX; He S; Chen H
Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
[TBL] [Abstract][Full Text] [Related]
22. GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78.
Song J; Liu W; Wang J; Hao J; Wang Y; You X; Du X; Zhou Y; Ben J; Zhang X; Ye M; Wang Q
Cell Death Dis; 2020 May; 11(5):352. PubMed ID: 32393740
[TBL] [Abstract][Full Text] [Related]
23. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
24. Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway.
Liu M; Wu S; Wu H; Zhou Y; Zhang X; Zhu D; Jiang J
J Transl Med; 2024 May; 22(1):510. PubMed ID: 38802900
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
26. Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma.
Wang J; Liang J; Li H; Han J; Jiang J; Li Y; Feng Z; Zhao R; Tian H
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33786609
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of LINC01426 promotes the progression and stemness in lung adenocarcinoma by enhancing the level of SHH protein to activate the hedgehog pathway.
Liu X; Yin Z; Xu L; Liu H; Jiang L; Liu S; Sun X
Cell Death Dis; 2021 Feb; 12(2):173. PubMed ID: 33568633
[TBL] [Abstract][Full Text] [Related]
28. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling.
Shi Y; Xu Y; Yao J; Yan C; Su H; Zhang X; Chen E; Ying K
J Cell Mol Med; 2021 Jul; 25(14):7013-7027. PubMed ID: 34121323
[TBL] [Abstract][Full Text] [Related]
29. ZDHHC11B is decreased in lung adenocarcinoma and inhibits tumorigenesis via regulating epithelial-mesenchymal transition.
Dai H; Wu R; Zhang J; Dou R; Xu M; Wang J; Wang J; Su F; Zhang T
Cancer Med; 2023 Aug; 12(16):17212-17222. PubMed ID: 37434393
[TBL] [Abstract][Full Text] [Related]
30. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
32. miR-3648 promotes lung adenocarcinoma-genesis by inhibiting SOCS2 (suppressor of cytokine signaling 2).
Tu Y; Mei F
Bioengineered; 2022 Feb; 13(2):3044-3056. PubMed ID: 35037826
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERβ2/5 pathway.
Hexiao T; Yuquan B; Lecai X; Yanhong W; Li S; Weidong H; Ming X; Xuefeng Z; Gaofeng P; Li Z; Minglin Z; Zheng T; Zetian Y; Xiao Z; Yi C; Lanuti M; Jinping Z
Aging (Albany NY); 2021 Jan; 13(2):2604-2625. PubMed ID: 33428600
[TBL] [Abstract][Full Text] [Related]
34. CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.
Yao Y; Hua Q; Zhou Y
Biochem Biophys Res Commun; 2019 Jan; 508(1):37-45. PubMed ID: 30470570
[TBL] [Abstract][Full Text] [Related]
35. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma.
Li W; Pan T; Jiang W; Zhao H
Biomed Pharmacother; 2020 Sep; 129():110217. PubMed ID: 32559619
[TBL] [Abstract][Full Text] [Related]
36. TFAP2A Induced KRT16 as an Oncogene in Lung Adenocarcinoma via EMT.
Yuanhua L; Pudong Q; Wei Z; Yuan W; Delin L; Yan Z; Geyu L; Bo S
Int J Biol Sci; 2019; 15(7):1419-1428. PubMed ID: 31337972
[No Abstract] [Full Text] [Related]
37. STRIP2, a member of the striatin-interacting phosphatase and kinase complex, is implicated in lung adenocarcinoma cell growth and migration.
Qiu LM; Sun YH; Chen TT; Chen JJ; Ma HT
FEBS Open Bio; 2020 Mar; 10(3):351-361. PubMed ID: 31901223
[TBL] [Abstract][Full Text] [Related]
38. MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma.
Tang Q; Li W; Zheng X; Ren L; Liu J; Li S; Wang J; Du G
Signal Transduct Target Ther; 2020 Dec; 5(1):279. PubMed ID: 33262323
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
